Oxford Immunotec Global PLC (NASDAQ:OXFD)

12.53
Delayed Data
As of Apr 20
 -0.41 / -3.17%
Today’s Change
10.00
Today|||52-Week Range
19.51
-10.31%
Year-to-Date
No recent news for Oxford Immunotec Global PLC.

Today’s Trading

Previous close12.94
Today’s open12.90
Day’s range12.48 - 12.95
Volume53,390
Average volume (3 months)192,110
Market cap$335.8M
Data as of 4:00pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)-38.00%
Earnings growth (this year)+29.71%
Earnings growth (next 5 years)--
Revenue growth (last year)+19.75%
P/E ratioNM
Price/Sales3.22
Price/Book3.80

Competitors

 Today’s
change
Today’s
% change
CLDXCelldex Therapeutics...+0.02+3.09%
VCYTVeracyte Inc+0.35+6.07%
VIVOMeridian Bioscience ...-0.20-1.36%
CALACalithera Bioscience...-0.35-5.43%
Data as of 4:00pm ET, 04/20/2018

Financials

Next reporting dateMay 1, 2018
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$103.1M
Annual profit (last year)-$32.9M
Net profit margin-31.90%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chief Executive Officer &
Executive Director
Peter James Wrighton-Smith
Chief Operating Officer
Stefan C. Linn
Corporate headquarters
Abingdon, Oxfordshire

Forecasts